Amedisys (AMED) Worth Watching: Stock Moves 6.9% Higher - Tale of the Tape

Amedisys Inc. AMED was a big mover last session with its shares rising nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above past one month's volatile price range of $13.14 to $14.50.

This provider of home health and hospice care services has seen 6 positive estimate revisions over the past 30 days. The Zacks Consensus Estimate has also moved considerably higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday's rally can turn into more strength down the road.

Amedisys currently holds a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Investors interested in the same industry may also consider stocks like RadNet, Inc. RDNT, PharMerica Corp. PMC and Almost Family Inc. (AFAM). All three stocks bear the same Zacks Rank as Amedisys.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ALMOST FAMILY AFAM: Free Stock Analysis Report
 
AMEDISYS INC AMED: Free Stock Analysis Report
 
PHARMERICA CORP PMC: Free Stock Analysis Report
 
RADNET INC RDNT: Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!